Koers Shengtai Pharmaceutical, Inc. Other OTC
Aandelen
SGTI
US8232142005
Farmaceutische producten
Omzet 2011 | 172 mln. 158 mln. | Omzet 2012 | 179 mln. 165 mln. | Marktkapitalisatie | 14,86 mln. 13,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2011 | 7 mln. 6,45 mln. | Nettowinst (verlies) 2012 | 1 mln. 921K | EV/omzet 2011 | 0,4 x |
Nettoschuld 2011 | 55,79 mln. 51,39 mln. | Nettoschuld 2012 | 86,75 mln. 79,9 mln. | EV/omzet 2012 | 0,57 x |
K/w-verhouding 2011 |
1,63
x | K/w-verhouding 2012 |
14,1
x | Werknemers | - |
Dividendrendement 2011 * |
-
| Dividendrendement 2012 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Qing Tai Liu
CHM | Chairman | 65 | - |
Yong Qiang Wang
BRD | Director/Board Member | 54 | 01-04-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qing Tai Liu
CHM | Chairman | 65 | - |
Yong Qiang Wang
BRD | Director/Board Member | 54 | 01-04-06 |
Ji Hui Hao
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,61% | 44,15 mld. | |
+23,29% | 23,02 mld. | |
+19,25% | 15,33 mld. | |
+12,90% | 13,74 mld. | |
+50,31% | 12,16 mld. | |
-10,06% | 6,84 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+13,88% | 5,66 mld. |